| Bioactivity | fMIFL is an FPR1 agonist. fMIFL can activate several signaling pathways responsible for various neutrophil functions, such as adhesion, chemotaxis, secretion of granule exocytosis, and the production of superoxide anions. fMIFL can be used in research on bacterial infections and tissue damage[1]. |
| CAS | 112275-26-0 |
| Sequence | {N-formyl}-Met-Ile-Phe-Leu |
| Shortening | {N-formyl}-MIFL |
| Formula | C27H42N4O6S |
| Molar Mass | 550.71 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Dalpiaz A, et al. Studies on human neutrophil biological functions by means of formyl-peptide receptor agonists and antagonists. Curr Drug Targets Immune Endocr Metabol Disord. 2003 Mar;3(1):33-42. |